Arcturus Therapeutics (ARCT) is continuing to evaluate the use of LUNAR-CF [ARCT-032] for the treatment of patients with Cystic Fibrosis [CF]. Read our latest report on the stock here.
Nipocalimab was well-tolerated over the six-month study period, with no major safety signals observed. The most common adverse events (AEs) were infections and infestations: 60.4% (n=32) in the ...
Union Home Minister Amit Shah on Thursday launched a scathing attack on Jharkhand Chief Minister Hemant Soren and asserted that the BJP would bid farewell to “Soren and company” on November 23. Shah ...